Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -4.96
- Piotroski Score 1.00
- Grade N/A
- Symbol (BACA)
- Company Berenson Acquisition Corp. I
- Price $10.64
- Changes Percentage (0%)
- Change -$0
- Day Low $10.64
- Day High $10.65
- Year High $10.74
Berenson Acquisition Corp. I does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses its search on a target business that operate in the software and technology-enabled services industry. The company was incorporated in 2021 and is based in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/04/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.37
- Trailing P/E Ratio -7.79
- Forward P/E Ratio -7.79
- P/E Growth -7.79
- Net Income $-20,814,064
Income Statement
Quarterly
Annual
Latest News of BACA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Coca-Cola and Bacardi testing canned rum and cokes
Coca-Cola and Bacardi are teaming up to launch a rum and coke canned cocktail, tapping into the fast-growing market. With plans for an international rollout and potential U.S. launch in 2025, the move...
By CNBC | 3 weeks ago -
NIH-funded trial finds HIV drug abacavir linked to higher cardiovascular risk
NIH-funded REPRIEVE trial finds that HIV drug abacavir is associated with a higher risk of cardiovascular events. A daily statin regimen was shown to reduce MACE risk by over one-third. Further resear...
By Yahoo! Finance | 2 months ago
